Thurston Springer Miller Herd & Titak’s Gilead Sciences GILD Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$148K	Buy	1,170 +430	+58%	+$56.7K	0.05%	293
2026 Q1	$103K	Sell	740 -24	-3%	-$3.36K	0.04%	372
2025 Q4	$93.8K	Buy	764 +696	+1,024%	+$84.6K	0.03%	372
2025 Q3	$7.55K	Sell	68 -486	-88%	-$55.2K	0.01%	370
2025 Q2	$61.4K	Buy	554 +71	+15%	+$7.56K	0.01%	615
2025 Q1	$54.1K	Buy	483 +257	+114%	+$26.5K	0.01%	610
2024 Q4	$20.9K	Buy	226 +85	+60%	+$7.65K	﹤0.01%	717
2024 Q3	$11.8K	Hold	141	–	–	﹤0.01%	970
2024 Q2	$9.67K	Buy	+141	New	+$9.41K	﹤0.01%	1031

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's GILD Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Gilead Sciences (GILD) stake by 58% in Q2 2026, buying an estimated $56.7K and bringing the position to 1,170 shares worth $148K. The position accounts for 0.05% of the portfolio, ranked #293.

Thurston Springer Miller Herd & Titak first reported a position in GILD in Q2 2024 and has held it in 9 quarters since. 837 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Thurston Springer Miller Herd & Titak held 1,170 shares of Gilead Sciences worth $148K as of Q2 2026.
Thurston Springer Miller Herd & Titak bought 430 Gilead Sciences shares in Q2 2026, an estimated $56.7K.
Gilead Sciences made up 0.05% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #293 holding.
Thurston Springer Miller Herd & Titak first reported a position in Gilead Sciences in Q2 2024 and has held it in 9 quarters since.
837 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.